Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Murphy

Showing results (541-550 of 643) with videos related to

Pageof 65
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatmentL J Siever, T W Uhde, D C Jimerson, et al.
The Pharmacogenomics Journal|September 12, 2012
Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humansM A Fox, M G Panessiti, P R Moya, et al.
Journal of Neurochemistry|January 1, 1990
Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidaseD L Murphy, K B Sims, F Karoum, et al.
The American Journal of Psychiatry|November 1, 1991
Symptoms of eating disorders in patients with obsessive-compulsive disorderT A Pigott, M Altemus, C S Rubenstein, et al.
Archives of General Psychiatry|April 1, 1985
Attention dysfunction and psychopathology in college menM S Buchsbaum, R J Haier, A J Sostek, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1983
Growth hormone response to clonidine in obsessive-compulsive patientsL J Siever, T R Insel, D C Jimerson, et al.
Psychiatry Research|February 1, 1981
Physostigmine induction of depressive symptomatology in normal human subjectsS C Risch, R M Cohen, D S Janowsky, et al.
Biological Psychiatry|February 1, 1991
A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteersB A Lawlor, P A Newhouse, T J Balkin, et al.
Psychoneuroendocrinology|January 1, 1990
Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's diseaseP A Newhouse, T Sunderland, P K Narang, et al.
Psychopharmacology|January 1, 1987
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's diseaseT Sunderland, P N Tariot, R M Cohen, et al.
Pageof 65

Showing results (541-550 of 643) with videos related to

Sort By:
Pageof 65
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatmentL J Siever, T W Uhde, D C Jimerson, et al.
The Pharmacogenomics Journal|September 12, 2012
Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humansM A Fox, M G Panessiti, P R Moya, et al.
Journal of Neurochemistry|January 1, 1990
Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidaseD L Murphy, K B Sims, F Karoum, et al.
The American Journal of Psychiatry|November 1, 1991
Symptoms of eating disorders in patients with obsessive-compulsive disorderT A Pigott, M Altemus, C S Rubenstein, et al.
Archives of General Psychiatry|April 1, 1985
Attention dysfunction and psychopathology in college menM S Buchsbaum, R J Haier, A J Sostek, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1983
Growth hormone response to clonidine in obsessive-compulsive patientsL J Siever, T R Insel, D C Jimerson, et al.
Psychiatry Research|February 1, 1981
Physostigmine induction of depressive symptomatology in normal human subjectsS C Risch, R M Cohen, D S Janowsky, et al.
Biological Psychiatry|February 1, 1991
A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteersB A Lawlor, P A Newhouse, T J Balkin, et al.
Psychoneuroendocrinology|January 1, 1990
Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's diseaseP A Newhouse, T Sunderland, P K Narang, et al.
Psychopharmacology|January 1, 1987
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's diseaseT Sunderland, P N Tariot, R M Cohen, et al.
Pageof 65